{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:58:35Z","timestamp":1785279515206,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc. Diabetol. \u2013 Endocrinol. Rep."],"DOI":"10.1186\/s40842-026-00315-2","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:02:11Z","timestamp":1785276131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Baseline versus cumulative cholesterol, high-density lipoprotein, and glucose index and stroke risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: evidence from the CHARLS study"],"prefix":"10.1186","volume":"12","author":[{"given":"Chen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"20","key":"315_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"issue":"20","key":"315_CR2","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"issue":"21","key":"315_CR3","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011\u20132020. JAMA. 2024;331(21):1858\u201360.","journal-title":"JAMA"},{"issue":"10258","key":"315_CR4","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"Global burden","year":"2020","unstructured":"Global burden. of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"10","key":"315_CR5","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","volume":"23","author":"VL Feigin","year":"2024","unstructured":"Feigin VL, Abate MD, Abate YH, Abd ElHafeez S, Abd-Allah F, Abdelalim A, et al. Global, regional, and national burden of stroke and its risk factors, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(10):973\u20131003.","journal-title":"Lancet Neurol"},{"issue":"8","key":"315_CR6","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1681\/ASN.0000000658","volume":"36","author":"Z Xie","year":"2025","unstructured":"Xie Z, Yu C, Cui Q, Zhao X, Zhuang J, Chen S, et al. Global Burden of the Key Components of Cardiovascular-Kidney-Metabolic Syndrome. J Am Soc Nephrol. 2025;36(8):1572\u201384.","journal-title":"J Am Soc Nephrol"},{"key":"315_CR7","doi-asserted-by":"publisher","first-page":"111926","DOI":"10.1016\/j.diabres.2024.111926","volume":"218","author":"V Trimarco","year":"2024","unstructured":"Trimarco V, Izzo R, Pacella D, Virginia Manzi M, Trama U, Lembo M, et al. Increased prevalence of cardiovascular-kidney-metabolic syndrome during COVID-19: A propensity score-matched study. Diabetes Res Clin Pract. 2024;218:111926.","journal-title":"Diabetes Res Clin Pract"},{"key":"315_CR8","doi-asserted-by":"crossref","unstructured":"Gao Q, Ren W, Du X, Yu Y, Ma Z, Cui Y, et al. Sex-specific associations between depression and cardiovascular-kidney-metabolic syndrome progression: a national cohort study. Eur J Prev Cardiol. 2026.","DOI":"10.1093\/eurjpc\/zwag135"},{"issue":"1","key":"315_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5853\/jos.2022.02306","volume":"25","author":"O Mosenzon","year":"2023","unstructured":"Mosenzon O, Cheng AY, Rabinstein AA, Sacco S. Diabetes and Stroke: What Are the Connections? J Stroke. 2023;25(1):26\u201338.","journal-title":"J Stroke"},{"issue":"12","key":"315_CR10","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1007\/s11010-025-05379-9","volume":"480","author":"Z Xu","year":"2025","unstructured":"Xu Z, Yang S, Tan Y, Zhang Q, Wang H, Tao J, et al. Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms\u2013a comprehensive review. Mol Cell Biochem. 2025;480(12):6039\u201375.","journal-title":"Mol Cell Biochem"},{"key":"315_CR11","doi-asserted-by":"publisher","first-page":"1809079","DOI":"10.3389\/fendo.2026.1809079","volume":"17","author":"X Zhu","year":"2026","unstructured":"Zhu X, Liu X, An J, He Q, Wang S, Zhang Z, et al. Pulse pressure mediation and hypertension modulation: the impact of TyG index on renal function deterioration in CKD patients under the CKM syndrome framework. Front Endocrinol (Lausanne). 2026;17:1809079.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"315_CR12","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"315_CR13","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/oby.23503","volume":"30","author":"A Gastaldelli","year":"2022","unstructured":"Gastaldelli A. Measuring and estimating insulin resistance in clinical and research settings. Obes (Silver Spring). 2022;30(8):1549\u201363.","journal-title":"Obes (Silver Spring)"},{"issue":"2","key":"315_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jdi.14343","volume":"16","author":"A Mansoori","year":"2024","unstructured":"Mansoori A, Nosrati M, Dorchin M, Mohammadyari F, Derakhshan-Nezhad E, Ferns G, et al. A novel index for diagnosis of type 2 diabetes mellitus: Cholesterol, High density lipoprotein, and Glucose (CHG) index. J Diabetes Invest. 2024;16(2):309\u201314.","journal-title":"J Diabetes Invest"},{"key":"315_CR15","doi-asserted-by":"crossref","unstructured":"Xiao Q, Huang W, Zhuang Y, Chen Y, Peng G, Li Y. Evaluating the role of CHG index in predicting stroke risk among adults with varying glucose regulation. Aging Clin Exp Res. 2025;37(1).","DOI":"10.1007\/s40520-025-03243-w"},{"key":"315_CR16","doi-asserted-by":"crossref","unstructured":"Mo D, Zhang P, Zhang M, Dai H, Guan J. Cholesterol, high-density lipoprotein, and glucose index versus triglyceride\u2013glucose index in predicting cardiovascular disease risk: a cohort study. Cardiovasc Diabetol. 2025;24(1).","DOI":"10.1186\/s12933-025-02675-y"},{"issue":"10","key":"315_CR17","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1161\/HYPERTENSIONAHA.122.19912","volume":"79","author":"V Trimarco","year":"2022","unstructured":"Trimarco V, Izzo R, Morisco C, Mone P, Virginia Manzi M, Falco A, et al. High HDL (High-Density Lipoprotein) Cholesterol Increases Cardiovascular Risk in Hypertensive Patients. Hypertension. 2022;79(10):2355\u201363.","journal-title":"Hypertension"},{"key":"315_CR18","doi-asserted-by":"crossref","unstructured":"Li FH, Li YY, Zhang Y, Yang L, Pan SK, Liu DW et al. Emerging multidimensional biomarker system for cardiovascular-kidney-metabolic syndrome: from multi-omics integration to clinical artificial intelligence. Cardiovasc Diabetol. 2026.","DOI":"10.1186\/s12933-026-03178-0"},{"key":"315_CR19","doi-asserted-by":"publisher","first-page":"1818442","DOI":"10.3389\/fendo.2026.1818442","volume":"17","author":"Y Shen","year":"2026","unstructured":"Shen Y, Han J, Ding X, Editorial. Novel strategies for the clinical management of cardiovascular-kidney-metabolic syndrome. Front Endocrinol (Lausanne). 2026;17:1818442.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"315_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort Profile: The China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2012;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"key":"315_CR21","doi-asserted-by":"crossref","unstructured":"Zhang Y, Zhu Y, He Y, Yan Y, Zhao Q, Du Y. Association of cumulative cholesterol-HDL-glucose index with blood pressure changes and risk of new-onset hypertension in middle-aged and older adults: a cohort study. Cardiovasc Diabetol. 2026;25(1).","DOI":"10.1186\/s12933-026-03081-8"},{"key":"315_CR22","doi-asserted-by":"crossref","unstructured":"Yue Y, Li P, Sun Z, Murayama R, Li Z, Hashimoto K et al. Association of novel triglyceride-glucose-related indices with incident stroke in early-stage cardiovascular-kidney-metabolic syndrome. Cardiovasc Diabetol. 2025;24(1).","DOI":"10.1186\/s12933-025-02854-x"},{"key":"315_CR23","doi-asserted-by":"crossref","unstructured":"Ren Q, Huang Y, Liu Q, Chu T, Li G, Wu Z. Association between triglyceride glucose-waist height ratio index and cardiovascular disease in middle-aged and older Chinese individuals: a nationwide cohort study. Cardiovasc Diabetol. 2024;23(1).","DOI":"10.1186\/s12933-024-02336-6"},{"key":"315_CR24","doi-asserted-by":"crossref","unstructured":"Huo R-R, Liao Q, Zhai L, You X-M, Zuo Y-L. Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on stroke risk and the mediating role of TyG in middle-aged and older Chinese adults: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1).","DOI":"10.1186\/s12933-024-02122-4"},{"key":"315_CR25","doi-asserted-by":"crossref","unstructured":"Zeng Y, Zhou D, Chen Y, Huo G. Association of cholesterol, high-density lipoprotein, and glucose index and its modified indices with the risk of stroke: insights from CHARLS. BMC Neurol. 2025;26(1).","DOI":"10.1186\/s12883-025-04575-w"},{"issue":"5","key":"315_CR26","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/oby.23154","volume":"29","author":"C Gallagher","year":"2021","unstructured":"Gallagher C, Corl A, Dietz WH. Weight Can\u2019t Wait: A Guide to Discussing Obesity and Organizing Treatment in the Primary Care Setting. Obes (Silver Spring). 2021;29(5):821\u20134.","journal-title":"Obes (Silver Spring)"},{"issue":"2","key":"315_CR27","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/dom.70338","volume":"28","author":"R Tian","year":"2026","unstructured":"Tian R, Tian X, Chen S, Li X, Zheng M, Wu S, et al. Association of cumulative exposure to cholesterol, high-density lipoprotein, and glucose index with the risk of cardiovascular disease and all-cause mortality: A longitudinal cohort study. Diabetes Obes Metab. 2026;28(2):1453\u201362.","journal-title":"Diabetes Obes Metab"},{"key":"315_CR28","doi-asserted-by":"crossref","unstructured":"Yang Y, Li C, Hong Y, Sun J, Chen G, Ji K. Association between functional dependence and cardiovascular disease among middle-aged and older adults: Findings from the China health and retirement longitudinal study. Heliyon. 2024;10(18).","DOI":"10.1016\/j.heliyon.2024.e37821"},{"issue":"2","key":"315_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/endocrines5020011","volume":"5","author":"B Arneth","year":"2024","unstructured":"Arneth B. Mechanisms of Insulin Resistance in Patients with Obesity. Endocrines. 2024;5(2):153\u201365.","journal-title":"Endocrines"},{"key":"315_CR30","doi-asserted-by":"crossref","unstructured":"M\u0142ynarska E, Czarnik W, Dzie\u017ca N, J\u0119draszak W, Majchrowicz G, Prusinowski F, et al. Type 2 diabetes mellitus: new pathogenetic mechanisms, treatment and the most important complications. Int J Mol Sci. 2025;26(3).","DOI":"10.3390\/ijms26031094"},{"issue":"8","key":"315_CR31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1080\/00325481.2020.1771047","volume":"132","author":"C Wysham","year":"2020","unstructured":"Wysham C, Shubrook J. Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications. Postgrad Med. 2020;132(8):676\u201386.","journal-title":"Postgrad Med"},{"issue":"5","key":"315_CR32","first-page":"671","volume":"36","author":"AA da Silva","year":"2020","unstructured":"da Silva AA, do Carmo JM, Li X, Wang Z, Mouton AJ, Hall JE. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited. Can J Cardiol. 2020;36(5):671\u201382.","journal-title":"Can J Cardiol"},{"key":"315_CR33","doi-asserted-by":"crossref","unstructured":"Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21(5).","DOI":"10.3390\/ijms21051835"},{"issue":"4","key":"315_CR34","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1161\/STROKEAHA.121.034299","volume":"53","author":"M Koch","year":"2022","unstructured":"Koch M, Aroner SA, Fitzpatrick AL, Longstreth WT, Furtado JD, Mukamal KJ, et al. HDL (High-Density Lipoprotein) Subspecies, Prevalent Covert Brain Infarcts, and Incident Overt Ischemic Stroke: Cardiovascular Health Study. Stroke. 2022;53(4):1292\u2013300.","journal-title":"Stroke"},{"key":"315_CR35","doi-asserted-by":"crossref","unstructured":"Papaetis GS, Sacharidou A, Michaelides IC, Mikellidis KC, Karvounaris SA. Insulin resistance, hyperinsulinemia and atherosclerosis: insights into pathophysiological aspects and future therapeutic prospects. Curr Cardiol Rev. 2025;21(1).","DOI":"10.2174\/011573403X314035241006185109"},{"key":"315_CR36","doi-asserted-by":"crossref","unstructured":"Mutruc V, Bologa C, \u0218orodoc V, Ceasovschih A, Mor\u0103ra\u0219u BC, \u0218orodoc L, et al. Cardiovascular\u2013kidney\u2013metabolic syndrome: a new paradigm in clinical medicine or going back to basics? J Clin Med. 2025;14(8).","DOI":"10.3390\/jcm14082833"},{"issue":"7","key":"315_CR37","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793\u2013801.","journal-title":"J Clin Invest"},{"key":"315_CR38","doi-asserted-by":"crossref","unstructured":"P\u00fcschel GP, Klauder J, Henkel J, Macrophages L-G, Inflammation. Insulin resistance and hyperinsulinemia: a mutual ambiguous relationship in the development of metabolic diseases. J Clin Med. 2022;11(15).","DOI":"10.3390\/jcm11154358"},{"key":"315_CR39","doi-asserted-by":"publisher","first-page":"177031","DOI":"10.1016\/j.ejphar.2024.177031","volume":"984","author":"K Hetherington","year":"2024","unstructured":"Hetherington K, Thomas J, Nicholls SJ, Barsha G, Bubb KJ. Unique cardiometabolic factors in women that contribute to modified cardiovascular disease risk. Eur J Pharmacol. 2024;984:177031.","journal-title":"Eur J Pharmacol"},{"key":"315_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2020.07.019","volume":"159","author":"J Soppert","year":"2020","unstructured":"Soppert J, Lehrke M, Marx N, Jankowski J, Noels H. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev. 2020;159:4\u201333.","journal-title":"Adv Drug Deliv Rev"},{"key":"315_CR41","doi-asserted-by":"crossref","unstructured":"Roerecke M. Alcohol\u2019s impact on the cardiovascular system. Nutrients. 2021;13(10).","DOI":"10.3390\/nu13103419"}],"container-title":["Cardiovascular Diabetology \u2013 Endocrinology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-026-00315-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40842-026-00315-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-026-00315-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:02:13Z","timestamp":1785276133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40842-026-00315-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1186\/s40842-026-00315-2","relation":{},"ISSN":["3059-4057"],"issn-type":[{"value":"3059-4057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Review Committee of Peking University, and were conducted in accordance with the Declaration of Helsinki (as revised in 2013). The participants provided their written informed consent to participate in this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"49"}}